SODIUM POLYSTYRENE SULFONATE
SODIUM POLYSTYRENE SULFONATE for suspension
Approved
Approval ID
fd9b192f-51f3-4737-be14-1970327f39aa
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 5, 2023
Manufacturers
FDA
Belcher Pharmaceuticals, LLC
DUNS: 965082543
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
SODIUM POLYSTYRENE SULFONATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code62250-660
Application NumberANDA205727
Product Classification
M
Marketing Category
C73584
G
Generic Name
SODIUM POLYSTYRENE SULFONATE
Product Specifications
Route of AdministrationORAL, RECTAL
Effective DateOctober 5, 2023
FDA Product Classification
INGREDIENTS (1)
SODIUM POLYSTYRENE SULFONATEActive
Quantity: 4.1 meq in 1 g
Code: 1699G8679Z
Classification: ACTIR